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Abstract
BACKGROUND 
The results obtained to date concerning food groups, diet quality and colorectal 
cancer (CRC) risk vary according to criteria used and the study populations.
AIM 
To study the relationships between food groups, diet quality and CRC risk, in an 
adult population of the Basque Country (North of Spain).
METHODS 
This observational study included 308 patients diagnosed with CRC and 308 age- 
and sex-matched subjects as controls. During recruitment, dietary, 
anthropometric, lifestyle, socioeconomic, demographic and health status 
information was collected. Adherence to the dietary recommendations was 
evaluated utilizing the Healthy Eating Index for the Spanish Diet and the 
MedDietScore. Conditional logistic regressions were used to evaluate the 
associations of food group intakes, diet quality scores, categorized in tertiles, with 
CRC risk.
RESULTS 
The adjusted models for potential confounding factors showed a direct association 
between milk and dairy products consumption, in particular high-fat cheeses 
[odds ratio (OR) third tertile vs first tertile = 1.87, 95% confidence intervals (CI): 
1.11-3.16], and CRC risk. While the consumption of fiber-containing foods, 
especially whole grains (OR third tertile vs first tertile = 0.62, 95%CI: 0.39-0.98), 
and fatty fish (OR third tertile vs first tertile = 0.53, 95%CI: 0.27-0.99) was 
associated with a lower risk for CRC. Moreover, higher MD adherence was 
associated with a reduced CRC risk in adjusted models (OR third tertile vs first 
tertile = 0.40, 95%CI: 0.20-0.80).
CONCLUSION 
Direct associations were found for high-fat cheese, whereas an inverse relation 
was reported for fiber-containing foods and fatty fish, as well as adherence to a 
Mediterranean dietary pattern.
Key words: Colorectal cancer; Food group; Dietary quality; Mediterranean diet; Risk-
factors; Case-control study
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: This matched case-control study supports the role of diet in colorectal cancer 
(CRC) risk. The results suggest that high consumption of high-fat cheeses is associated 
with CRC risk, whereas, a high intake of fiber-containing foods, especially whole grains, 
and fatty fish, as well as adherence to the Mediterranean dietary pattern, was associated 
with a lower risk for CRC. Future studies are needed to better understand the influence of 
the dietary habits on CRC prevention in this population that can provide leads for the 
design and tailoring of future interventions, and guide counselling strategies for promoting 
a healthy lifestyle.
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Colorectal cancer (CRC) is a major public health challenge worldwide. CRC is the 
third-most commonly diagnosed malignancy and the fourth leading cause of cancer 
deaths in the world, accounting for approximately 1.8 million new cases and almost 
900000 deaths in 2018[1]. In Europe, CRC is the leading malignancy in terms of 
incidence and the second in mortality in both sexes[2]. CRC is linked to western 
lifestyles, in particular, to diet, physical inactivity, smoking, alcohol consumption, and 
body weight[3,4].
Epidemiological evidence suggests that dietary factors may both protect against and 
promote the development of CRC. A comprehensive review[5] shows robust evidence 
about the protective role of dietary fiber. Other foods, such as milk or garlic, also may 
be protective. Conversely, red meat and processed meat intake and alcoholic drinks 
increase CRC risk. This food group approach has the advantage of reducing some of 
the problems inherent to analyses of nutrient intake (e.g., inaccuracy and 
incompleteness of food-composition tables). Furthermore, it offers an advantage from 
a preventive perspective since food group results are easier to transform into dietary 
recommendations than those of nutrients[6].
In this regard, foods are not consumed in isolation but as part of a dietary pattern; 
therefore, the actual effect of diet on disease risk may be observed only when all 
components are considered jointly[6]. For this purpose, several diet quality indexes 
have been developed using point systems to measure whole diet quality based on the 
alignment of food choices with dietary recommendations. Some of these indices have 
been used to begin assessing the relationships between overall diet quality and CRC 
risk, and the results show that high scores in these indices are associated with a lower 
CRC risk[7-10]. However, the results vary considerably according to the index used and 
other factors such as sex and age. Therefore, there is a need to further examine these 
relationships in diverse population studies.
The current case-control study was undertaken in the North of Spain to elucidate 
the relationships between food group consumption, diet quality and CRC risk, and 
identify possible differences in consumption depending on tumor location, in an adult 
population that participated in a CRC screening programme (CRCSP) in the Basque 
Country. To our knowledge, this is the first study in the Basque country population, in 
which both CRC incidence and mortality have increased in recent years[11]. There are 
few studies in this regard in Spain[12,13]. And both in these Spanish studies and in others 
carried out in other Mediterranean countries controls were apparently healthy subjects 
without clinical symptoms or signs of any type of cancer[14].
MATERIALS AND METHODS
Study subjects
This is an observational, matched case-control study in a population group residing in 
the Basque Country (North of Spain). Participants in this study were recruited from 
among patients attending any of the three hospitals of the Osakidetza/Basque Health 
Service (Basurto, Galdakao and Donostia) members of the Basque Country CRCSP. To 
be eligible for this CRCSP, the patients had to be aged between 50 and 69, 
asymptomatic for colorectal symptoms and registered with the Osakidetza/Basque 
Health Service[11]. These inclusion criteria were applied to both case and control group, 
that is, controls fulfilled the same eligibility criteria defined for the cases, with the 
exception of the disease (outcome). Recruitment and data collection for the present 
study were conducted between 2014 and 2016.
All the patients who were newly diagnosed with CRC (n = 601) were invited to 
participate in this study. Of those, 283 refused to participate in the study, and 10 were 
excluded due to missing information. Ultimately, 308 subjects (66.2% men) consented 
to participate in the survey and completed all the questionnaires. In addition, for each 
case, three age- (± 9.0 years) and sex-matched control patients were randomly sought 
from the list of CRC-free subjects (n = 1836) who participated in the CRCSP during the 
same period as the cases. The matched controls were patients with positive results 
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(abnormal) for immunochemical fecal occult blood test and negative colonoscopy 
results (normal). The participation rate of the controls was 37.6%, and 17 subjects were 
excluded due to missing information. Finally, the matched case-to-control ratio was 
1:1, and the final data set included 308 cases who were diagnosed with CRC and 308 
age- and sex-matched controls. Further details on recruitment and data collection have 
been described elsewhere[15]. The main advantage of the present study compared to 
other above-mentioned researches[12-14] is that we confirmed that controls were free of 
the disease through colonoscopy. Colonoscopy was used as diagnostic criteria to 
identify the cases in order to avoid false positives and negatives.
The pathological staging was based on the 7th edition of the AJCC cancer staging 
manual[16] as follows: I (57.1%), IIA (13.6%), IIB (1.0%), IIC (0.3%), IIIA (7.5%), IIIB 
(14.6%), IIIC (1.9%), IVA (2.9%), and IVB (1.0%). The location of the cancer was distal 
in 76% and proximal (to the splenic flexure of the colon) in 24.0% of the samples. 
Concerning the tumor grade classification, we adopted a two-grade classification that 
was divided into low grade (well or moderately differentiated) (80.5%) and high grade 
(poorly differentiated, anaplastic, or undifferentiated) (4.5%); the percentage of 
missing data for this classification was 14.9%.
Some of the cases had undergone surgical resection (73.7%) and/or adjuvant 
treatments, chemotherapy (34.1%), and chemotherapy and radiation (6.8%). The 
percentages of subjects according to the type of surgical procedure were as follows: 
26.3% sigmoidectomy, 17.5% right hemicolectomy resection, 18.8% low anterior 
resection, 6.5% left hemicolectomy resection, 2.3% transverse colectomy, 1.0% 
abdominoperineal resection, 1.0% total colectomy, and 0.3% transanal endoscopic 
operation. The cases were invited to take part in this survey at least one month after 
finishing their last treatment (surgery, chemotherapy or radiotherapy) (median, 1.3 
years; range, 0.1 to 4.2 years). All the clinical data were obtained from the Basque 
Country's population-based CRCSP database, which links patient medical records and 
clinical databases and reviewed by expert staff. This review allowed the 
monitorization of all cases from the submission of the sample through the analysis, 
colonoscopy, pathology and follow-up.
This study was conducted according to the guidelines laid down in the Declaration 
of Helsinki, and all procedures involving patients were approved by the Clinical 
Research Ethics Committee of the Basque Country (reference numbers PI2011006 and 
PI2014042). Written informed consent was obtained from all the study participants. 
Consenting participants self-completed and returned a detailed food frequency 
questionnaire (FFQ) and one general questionnaire. The questions referred to the 
behaviors before participating in the CRCSP. Assistance from the study staff was 
available to help the patients to understand the items on the questionnaires. The 
quality management applied in the present study has been described in a previous 
article[15].
Dietary assessment
Diets were assessed using a short FFQ that was a modified version of the Rodríguez 
et al[17] (2008) questionnaire. This adaptation was validated with multiple 24-h recalls in 
the Basque general population[18] and in CRC diagnosed patients in a pilot of the 
present study[19]. It consists of 67 items and requires the subjects to recall the number of 
times each food item was consumed either per week or per month. This FFQ included 
specific questions about the frequency of intake of alcoholic beverages. Moreover, the 
respondents could also record the consumption of other foods that were not included 
on the food list.
Consumption frequencies were standardized to “per day” and multiplied by 
standard serving sizes (grams)[20]. For items that included several foods, each food’s 
contribution was estimated with weighting coefficients that were obtained from the 
usual consumption data[21]. Food items were then regrouped according to nutritional 
characteristics[22] and considering the potential contribution of food to the pathogenesis 
of CRC[23,24]. Details on the items included in each food group are shown in Table 1. All 
food items that were consumed were entered into DIAL 2.12 (2011 ALCE 
INGENIERIA)[25], a type of dietary assessment software, to estimate energy intake (
kilocalories/day, kcal/d).
Adherence to the dietary recommendations was evaluated utilizing the Healthy 
Eating Index for Spanish Diet (HEISD)[26] and the MedDietScore (MDS)[27], as 
previously described[19]. The theoretical range of the HEISD is 0-100 and of the MDS 0-
55, higher values of these scores indicate greater adherence to the dietary 
recommendations for the Spanish population and the Mediterranean diet pattern, 
respectively. HEISD was divided into the following categories: Poor diet (< 50 points), 
needs improvement (50-80 points) and proper diet (> 80 points)[26]; and the MDS into 
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Table 1 Food group definitions
Food group Food items
Red and processed meat
Red meat Beef, pork and lamb, minced meat, hamburgers, meatballs
Processed meat Ham, sausage, salami, mortadella, black pudding or blood sausage
Egg Egg
Fish White fish (hake, grouper, sole, cod) and fatty fish (sardine, tuna, salmon, mackerel)
Milk/dairy products
Non-cheese products Whole milk, semi-skimmed milk, skimmed milk, whole yogurt, skimmed yogurt and dairy desserts
Cheese Burgos cheese, curd, cottage and cheeses low in calories, mature, semi-mature and creamy cheese
Fiber-containing foods
Fruits Orange, tangerine, apple, pear, banana, peach, raisins, prunes, dried figs... natural fruit juices
Vegetables Salads, green beans, chard, spinach... garnish vegetables (eggplant, mushrooms, peppers...), garlic, onion
Whole grains Whole grain pasta, brown rice, whole grain cookies, whole breakfast cereals (Muesli, All-Bran)
Nuts Walnuts, almonds, hazelnuts, peanuts
Fat Vegetable oils (olive, sunflower, corn, soy), butter, margarine, mayonnaise
Sweet and added sugar Chocolate, breakfast cereals, cookies, muffins, donuts, honey, sugar, commercial fruit juice, soft-drinks, cakes, pies
Alcoholic beverages Beer, wine, hard cider, vermouth, whiskey, rum, gin, brandy, cocktails
the following ones: Low adherence to MD (0-34 points) and high adherence (> 35 
points). The cut-off point of MDS was established taking into account that scores 
below 34 points were associated with a higher risk of coronary heart disease, being the 
relative odds ≥ 1.42[27].
General questionnaire
A general questionnaire was used to gather information on weight status (self-
reported weight and height) and environmental factors [demographic factors: Age and 
sex; and lifestyle information: Physical exercise (PE) and smoking consumption]. These 
questions were taken from the Spanish Health Questionnaire[28]. Body mass index 
(BMI) estimated from self-reported height and weight was classified according to the 
World Health Organization criteria for those under 65 years of age[29] and according to 
the criteria proposed by Silva Silva Rodrigues et al[30] for those 65 years and older.
Additionally, socioeconomic and health status data were assessed with two indices 
that were obtained from the clinical databases developed by the Health Department of 
the Basque Government, namely the socioeconomic deprivation index (DI) and 
predictive risk modelling (PRM), respectively. The first one was estimated using the 
MEDEA project criteria[31], as has been described elsewhere[12] and was divided into 
quintiles (Q), with the first being the least disadvantaged and the fifth being the most 
disadvantaged. The DI was successfully assigned to 80.2% of participants, while the 
quality of the registered information did not permit the linking of the remaining 
19.8%.
The PRM is an index that is based on Adjusted Clinical Groups[32], Diagnostic Cost 
Groups/Hierarchical Condition Categories[33] and Clinical Risk Groups[34]. This index 
combines information about diagnoses, prescriptions, previous costs and the use of 
specific procedures. It is capable of predicting the use of health resources[35], and it was 
stratified into four levels (L); the first included participants with a risk of high health 
resource consumption and the fourth included those with low health resource 
consumption. The PRM was successfully assigned to 95.1% of participants, while the 
quality of the registered information did not permit the linking of the remaining 4.9%.
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics for Windows, version 
22.0 (IBM Corp., Armonk, NY, United States) and STATA 13.0 (StataCorp LP, TX, 
United States). Categorical variables are shown as a percentage, and continuous 
variables are shown as the means and standard deviations (SD). Normality was 
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checked using the Kolmogorov-Smirnov-Lilliefors test. Differences between 
continuous variables were calculated with a Wilcoxon test, and a McNemar’s test was 
used for categorical variables.
Conditional logistic regression was used to calculate odds ratios (ORs) and 95% 
confidence intervals (95%CI) for CRC risk according to tertiles of food group intakes 
and diet quality scores for unadjusted and adjusted models. Intake of all food groups 
and total diet quality scores were categorized into tertiles by the distribution in the 
control population, taking into account sex differences when they were significant. The 
lowest tertile was used as the reference group. Tertile cut-offs for HEISD were: 1st 
tertile (T1), 69; 2nd tertile (T2), 69-74.5 and 3rd tertile (T3), > 74.5; and for MDS: T1, < 35; T2, 
35-37 and T3, > 37.
Based on known risk factors for CRC[36-38], covariates in adjusted models included 
age, sex, weight status, energy intake, PE level, smoking status, intensity of smoking 
(in current and past smokers) and time not smoking (in past smokers), DI and PRM. 
Quantitative covariates (cigarettes/d and years not smoking) were dichotomized by 
mean or median, according to the normality test. We used the cut-off of Romaguera 
et al[39] to create two PE levels expressed in min/d of cycling/sports: Sedentary-light (< 
15 min/d) and moderate-vigorous (≥ 15 min/d). Age was dichotomized using the 
same age ranges that were used in the sample selection process (50-59 years old vs 60-
69 years old). Qualitative ones, such as DI and PRM were dichotomized taking into 
account the distribution of frequencies to obtain similar sample sizes for each category 
(DI, Q1-3 vs Q4-5; PRM, L3-4 vs L1-2). Energy intake was included as a quantitative variable 
in the adjusted models. We included participants with missing data for the covariates 
as a separate category. The reference categories were those that, according to the 
literature, have a lower CRC risk. All tests were 2-sided, and P values less than 0.05 
were considered statistically significant.
RESULTS
Comparisons of general characteristics between the cases and the controls are 
presented in Table 2. Significant differences between the cases and the controls were 
found for educational level, smoking and weight status, with a higher percentage of 
cases with low-medium educational level, past or current smoking status and with 
overweight/obesity compared to the controls (P < 0.01).
Table 3 shows food group intakes expressed as mean values and standard 
deviations according to case-control status. No significant differences were found 
between the two groups for the majority of foods groups, except for a higher 
consumption of eggs and a lower intake of whole grains in the cases than the controls (
P < 0.05).
The ORs for CRC risk by the main food group and food subgroup intakes are 
presented in Table 4 and 5, respectively. The adjusted ORs for CRC risk increased with 
higher red and processed meat, eggs, milk/dairy products intakes; whereas it 
decreased with higher fiber-containing foods and nut intakes. The food group with the 
highest adjusted OR for CRC risk was milk/dairy products. Fish consumption showed 
an association with CRC risk in the unadjusted analysis but not in the adjusted 
analysis. For some of these food groups, specifically for red and processed meat, fish, 
eggs and nuts, the null value 1 was contained in the confidence interval. Concerning 
the food subgroup intakes, the ORs for CRC risk increased with higher high-fat cheese 
intakes, while it decreased with higher fatty fish, in the adjusted analysis.
Supplementary Table 1 describes food group intakes of cases according to tumor 
location and their matched controls. Food group intakes were not substantially 
different between proximal and distal cancer cases, except for fish, milk/dairy 
products and fat. The fish consumption was higher in both case subgroups (proximal 
and distal cancer cases) in comparison with their matched controls (P < 0.001). 
However, the milk/dairy products intake was higher in proximal tumor cases and was 
lower in distal tumor cases than in their matched controls (P < 0.001). Finally, the fat 
intake was higher in proximal tumor cases in comparison with their matched controls 
(P < 0.05). The sample sizes did not allow the assessment of food group intakes related 
to disease risk, stratifying according to the tumor location.
The components and total scores of the HEISD and MDS are displayed in Table 6. 
According to HEISD, 91.9% of the participants (cases and controls) followed a diet 
classified as “needs improvement”, 7.6% followed a “good diet” and 0.5 followed a 
“poor diet”. Significant differences were neither observed in the HEISD classification 
nor the components scores nor in the total score. However, the total score for this 
Alegria-Lertxundi I et al. Diet and colorectal cancer risk
WJG https://www.wjgnet.com 4114 July 28, 2020 Volume 26 Issue 28
Table 2 General characteristics of the sample studied
Characteristics Cases (n = 308) Controls (n = 308) P value
Sex, men, n (%) 204 (66.2) 204 (66.2)
Age, yr, mean SD 61.5 5.2 61.1 5.5 0.093
Schooling, %
No education/primary education 36.7 29.2
Technical/secondary education 48.0 44.5





Housework 8.1 8.4 0.496
Last work, %
Employer or businessman/women 19.2 17.9
Steady salaried employee 75.0 71.8
Temporary salaried employee or member of a 
cooperative
0.6 4.5





Past/current 72.1 61.4 0.004
Time to quit smoking
≥ 11 yr 67.2 66.7
< 11 yr 32.8 33.3 0.931
Intensity of smoking1
≤ 15 cigarettes/d 50.7 33.1
> 15 cigarettes/d 49.3 66.9 0.003
Physical exercise, %
< 15 min/d of cycling/sports 79.2 65.9
≥ 15 min/d of cycling/sports 20.8 34.1 < 0.001
BMI, %
Underweight 6.5 7.8
Normal weight 26.0 34.1
Overweight/obesity 67.5 58.1
0.033
Energy intake (kcal/d), mean SD 1769.9 383.4 1736.6 388.2 0.172
DI,%2
Q1-3 47.1 65.6
Q4-5 18.8 29.5 < 0.001
PRM,%2
L1-2 15.6 12.3
L3-4 83.4 79.2 < 0.001
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1Percentages were calculated excluding never smokers. 
2Valid percentages. BMI: Body mass index; DI: Deprivation index (This index was successfully assigned to 80.2% of the study sample); L: Level; PRM: 
Predictive risk modelling (This index was successfully assigned to 95.1% of the study sample); Q: Quintile; SD: Standard deviation.
Table 3 Food group intakes of the sample studied
Food groups, g/d Cases (n = 308) Controls (n = 308) P value
mean SD mean SD
Red and processed meat 70.9 36.6 66.0 39.7 0.064
Red meat 49.7 30.5 46.1 31.0 0.130
Processed meat 21.2 16.6 19.9 17.2 0.155
Total fish 76.8 39.2 77.6 40.9 0.540
White fish 40.9 25.2 44.1 27.4 0.055
Fatty fish 35.9 22.6 33.6 24.1 0.236
Eggs 20.8 12.7 18.7 11.5 0.038
Milk/dairy products 264.7 153.4 271.0 119.4 0.310
Non-cheese dairy products 246.0 152.4 253.8 118.5 0.203
Total cheeses 18.8 17.4 17.1 16.8 0.172
Fresh cheeses1 6.9 10.3 7.1 13.3 0.867
Other cheeses2 11.7 11.8 10.1 10.7 0.172
Fiber-containing foods 570.3 243.9 564.8 214.1 0.761
Fruits (including natural juices) 330.2 202.5 322.6 168.2 0.791
Vegetables 202.1 88.8 200.6 90.9 0.803
Whole grains 14.4 19.9 18.8 23.4 0.012
Fat 35.5 6.9 34.6 6.4 0.064
Nuts 9.1 10.1 10.9 10.5 0.055
Sweets and added sugar 108.3 95.4 110.7 116.5 0.969
Alcoholic beverages 103.4 100.7 96.8 105.9 0.269
1Fresh cheeses, e.g., Burgos cheese and cheeses low in calories. 
2Other cheeses, mature, semi-mature and creamy cheeses. SD: Standard deviation.
dietary quality index and the score of diet variety components were higher for cases 
with the proximal location of cancer than for their matched controls (P < 0.05) (
Supplementary Table 2). No association was found between this index and risk of 
CRC, in the conditional logistic regressions.
Concerning the MDS, in the total sample, 39.8% showed low adherence to the MD 
and the remaining percentage had high adherence, without significant differences in 
the MDS classification between the cases and the controls. However, the scores for 
whole grains and total index were lower for cases than for controls (P < 0.05). This last 
result was confirmed using conditional logistic regressions, showing that those 
participants with higher MDS had a lower CRC risk than those with a lower score, in 
both unadjusted (model I: T3 vs T1, OR = 0.57, 95%CI: 0.37-0.89, P = 0.013) and adjusted 
models (model II: T3 vs T1, OR = 0.40, 95%CI: 0.20-0.80, P = 0.009). No significant 
differences were observed in total MDS between cases stratified by tumor location and 
their matched controls, but the total score was higher for cases with the proximal 
location of cancer than for those with distal location (P < 0.05) (Supplementary Table 2
). Moreover, the score for potatoes and whole grain components were lower for cases 
with the distal location of cancer than for their matched controls (P < 0.05).
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Table 4 Association between main food group in and colorectal cancer risk
Model I2 Model II3 Model III4
Main food group intakes1 No., case/control
OR (95%CI) OR (95%CI) OR (95%CI)
Red and processed meat
T1 90/102 1.00 1.00 1.00
T2 97/103 1.06 (0.72-1.57) 1.02 (0.61-1.72) 1.08 (0.61-1.94)
T3 121/109 1.32 (0.91-1.93) 1.65 (0.99-2.75) 1.26 (0.71-2.23)
P 0.314 < 0.001 -
Fish
T1 95/105 1.00 1.00 1.00
T2 77/103 0.82 (0.53-1.25) 0.97 (0.56-1.68) 0.83 (0.46-1.51)
T3 136/105 1.49 (1.01-2.20) 1.06 (0.62-1.79) 1.25 (0.68-2.29)
P 0.008 < 0.001 -
Eggs
T1 71/98 1.00 1.00 1.00
T2 107/116 1.15 (0.77-1.72) 1.04 (0.62-1.76) 0.97 (0.61-1.93)
T3 130/104 1.55 (1.03-2.33) 1.72 (1.00-2.94) 1.26 (0.71-2.23)
P 0.081 < 0.001 -
Milk/dairy products
T1 60/102 1.00 1.00 1.00
T2 127/104 2.05 (1.35-3.11) 2.02 (1.19-3.42) 1.97 (1.10-3.53)
T3 121/102 2.00 (1.31-3.05) 2.12 (1.25-3.84) 1.80 (0.95-3.42)
P < 0.001 < 0.001 -
Fiber-containing foods
T1 121/102 1.00 1.00 1.00
T2 75/101 0.60 (0.39-0.92) 0.47 (0.26-0.85) 0.49 (0.25-0.95)
T3 112/105 0.86 (0.58-1.28) 0.63 (0.36-1.11) 0.65 (0.35-1.21)
P 0.048 < 0.001 -
Nuts
T1 118/103 1.00 1.00 1.00
T2 118/108 0.97 (0.67-1.42) 0.87 (0.53-1.44) 0.70 (0.37-1.31)
T3 72/97 0.67 (0.43-0.97) 0.58 (0.34-1.00) 0.59 (0.30-1.18)
P 0.074 < 0.001 -
Fat
T1 86/100 1.00 1.00 1.00
T2 101/105 1.12 (0.75-1.67) 0.94 (0.56-1.59) 0.83 (0.45-1.51)
T3 121/100 1.34 (0.92-1.97) 1.46 (0.85-2.50) 1.25 (0.68-2.29)
P 0.297 < 0.001 -
Sweets and added sugar
T1 82/120 1.00 1.00 1.00
T2 120/103 1.47 (0.99-2.20) 1.67 (0.98-2.86) 1.88 (1.01-3.52)
T3 106/103 1.30 (0.87-1.94) 1.63 (0.92-2.89) 1.39 (0.72-2.67)
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P 0.159 < 0.001 -
Alcoholic beverage
T1 90/103 1.00 1.00 1.00
T2 107/101 1.20 (0.81-1.77) 1.05 (0.63-1.75) 1.10 (0.63-1.92)
T3 111/104 1.19 (0.83-1.72) 0.82 (0.50-1.36) 0.75 (0.42-1.32)
P 0.558 < 0.001
-
1Food groups consumption was categorized into tertiles according to the distribution in controls, and by sexes for food groups with significant differences 
according to sex; Tertiles of food groups: Red and processed meat, T1 < 47.7, T2 47.7-78.5, T3 > 78.5; Total fish, T1 < 42.8, T2 42.8-67.2, T3 > 67.2; eggs, T1 < 
15.7, T2 15.7-23.5, T3 > 23.5; Milk/dairy products, T1 < 72.0, T2 72.0-232.1, T3 > 232.1; Fat, T1 < 30.8, T2 30.8-34.8, T3 > 34.8; Nuts, T1 < 2.9, T2 2.9-12.8, T3 > 
12.8; Sweets and added sugar, T1 < 50.1, T2 50.1-117.3, T3 > 117.3; Tertiles of food groups for men: Fiber-containing foods, T1 < 424.3, T2 424.3-617.8, T3 > 
617.8; Alcoholic beverages, T1 < 66.7, T2 66.7-137.2, T3 > 137.2; Tertiles of food groups for women: Fiber-containing foods, T1 < 537.9, T2 537.9-723.6, T3 > 
723.6; T1 < 8.3; T2 8.3-85.7; T3 > 85.7. 
2Model I, analyses were performed using crude conditional logistic regression, without taking into account confounding factors. 
3Model II, analyses were performed using conditional logistic regression analysis adjusted for age (50-59 years old, 60-69 years old), sex, body mass index 
(underweight/normal weight, overweight/obesity), energy intake (kcal/d), physical exercise level (< 15 min/d of cycling/sports, ≥ 15 min/d), smoking 
status and intensity of smoking (never; past: quit smoking ≥ 11 years ago, quit < 11 years ago; Smoker: ≤ 15 cigarettes/d, > 15 cigarettes/d), Deprivation 
Index (quintile 1-3,quintile 4-5) and Predictive Risk Modelling (level 1-2, level 3-4), including food groups separately; participants with missing data for the 
confounding variables were included as a separate category for these variables. 
4Model III, model II including all the mean food groups. CI: Confidence interval; OR: Odd ratio; T: Tertile.
DISCUSSION
The results from this observational study indicate that high consumption of 
milk/dairy products, in particular high-fat cheeses, is associated with CRC risk, while 
a high intake of fiber-containing foods, specially whole grains, and fatty fish was 
associated with a lower risk for CRC. Moreover, a higher MD adherence in general 
and particularly a higher score for whole grains have been associated with a reduced 
CRC risk.
As other authors have previously reported[40] milk/dairy products were the food 
group with the highest adjusted OR for CRC risk, which is not in agreement with the 
probable evidence of protection of this food group against CRC[5]. Some cohort studies 
support the protective effect of total dairy products and milk[41-43]. This effect has been 
hypothetically associated with calcium, vitamin D, fats and other components such as 
lactoferrin or lactic bacteria in the case of fermented dairy products milk[41,42]. However, 
case-control studies published to date are heterogeneous and, on average, do not 
provide evidence of an association between total intake of total dairy products, milk, 
cheese or yogurt and CRC risk[41]. Regarding milk/dairy products consumption 
according to anatomical subsites of cases, the intake was higher in proximal tumor 
cases and lower in distal cases than in their matched controls. Although according to 
scientific literature, the effect of this food group seems to be similar across all locations 
of the bowel[43].
In general, epidemiological studies have not found evidence of either reduction or 
increase of CRC risk specifically associated with the consumption of cheese[41,42]. 
Although there are few pieces of research on cheese consumption that reported an 
inverse association with CRC[44] in the present research, high-fat cheeses are shown to 
be possible risk factors for CRC development. Some studies showed a positive 
relationship between fatty foods and CRC incidence[45]. Dairy products, e.g., mature, 
semi-mature and creamy cheeses, are rich in saturated fat, so this relationship might be 
due to the content of fat in these products. Several studies have suggested that high-fat 
consumption increases bile acid discharge. Moreover, an increase in the concentration 
of bile acids above physiological levels has been reported to promote CRC[46,47]. In any 
case, the association between milk/dairy products consumption and the risk of 
developing CRC is complex and some researchers indicated that the fat content 
contained within dairy products does not influence this association[43].
In line with previous studies[48-50], we also found that the consumption of fiber-
containing foods was inversely associated with CRC risk. Specifically, consumption of 
more than 424.3 g/d in men and 537.9 g/d in women of fiber-containing foods 
decreased CRC risk by about 50% (OR approximately 0.5) compared to lower 
consumption, in adjusted models. The preventive effect of dietary fiber can be 
explained by biological mechanisms that include increasing amounts of feces, 
decreasing gastrointestinal transit time, diluting intestinal cancer-causing factors, 
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Table 5 Association between food subgroup intakes and colorectal cancer risk
Model I2 Model II3 Model III4
Food subgroup intakes1 No., case/control
OR (95%CI) OR (95%CI) OR (95%CI)
Red meat
T1 88/101 1.00 1.00 1.00
T2 103/98 1.20 (0.81-1.79) 1.38 (0.82-2.34) 1.10 (0.62-1.96)
T3 117/109 1.22 (0.84-1.78) 1.41 (0.87-2.30) 1.17 (0.67-2.03)
P 0.534 < 0.001 -
Processed meat
T1 102/103 1.00 1.00 1.00
T2 82/99 0.84 (0.57-1.24) 0.62 (0.36-1.07) 0.67 (0.38-1.18)
T3 124/106 1.21 (0.83-1.77) 1.54 (0.91-2.60) 1.54 (0.88-2.70)
P 0.206 < 0.001 -
White fish
T1 95/105 1.00 1.00 1.00
T2 77/103 0.82 (0.53-1.25) 0.97 (0.56-1.68) 0.96 (0.36-2.53)
T3 136/105 1.49 (1.01-2.20) 1.06 (0.62-1.79) 1.29 (0.74-2.25)
P 0.008 < 0.001 -
Fatty fish
T1 119/110 1.00 1.00 1.00
T2 105/102 1.05 (0.71-1.55) 0.93 (0.56-1.55) 0.89 (0.43-1.69)
T3 74/96 0.72 (0.49-1.08) 0.50 (0.29-0.87) 0.53 (0.27-0.99)
P 0.145 < 0.001 -
Fresh cheese
T1 150/153 1.00 1.00 1.00
T2 224/33 0.64 (0.32-1.28) 1.06 (0.44-2.55) 1.11 (0.66-1.87)
T3 134/122 1.11 (0.80-1.55) 1.10 (0.70-1.72) 0.92 (0.58-1.46)
P 0.272 < 0.001 -
Other cheeses
T1 96/116 1.00 1.00 1.00
T2 71/75 1.16 (0.76-1.77) 1.51 (0.86-2.63) 1.83 (1.15-2.89)
T3 141/117 1.46 (1.01-2.12) 1.85 (1.12-3.05) 1.87 (1.11-3.16)
P 0.112 < 0.001 -
Fruits
T1 109/99 1.00 1.00 1.00
T2 98/110 0.82 (0.56-1.19) 1.08 (0.63-1.85) 1.03 (0.58-1.83)
T3 101/99 0.92 (0.62-1.37) 0.70 (0.40-1.22) 0.68 (0.37-1.26)
P 0.567 < 0.001 -
Vegetables
T1 97/102 1.00 1.00 1.00
T2 111/103 1.14 (0.76-1.71) 0.98 (0.55-1.73) 1.10 (0.60-2.04)
T3 100/103 1.03 (0.68-1.57) 0.94 (0.52-1.70) 1.10 (0.58-2.11)
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P 0.789 < 0.001 -
Whole grains
T1 144/128 1.00 1.00 1.00
T2 83/77 0.92 (0.62-1.38) 0.86 (0.52-1.42) 0.98 (0.58-1.65)
T3 81/103 0.68 (0.46-1.01) 0.62 (0.37-1.06) 0.62 (0.39-0.98)
P 0.135 < 0.001
1Food groups consumption was categorized into tertiles according to the distribution in controls, and by sexes for food groups with significant differences 
according to sex; Tertiles of food groups: Red meat, T1 < 33.5, T2 33.5-54.9, T3 > 54.9; Processed meat, T1 < 11.6, T2 11.6-22.8, T3 > 22.8; non-cheese dairy, T1 < 
225.0, T2 225.0-325.0, T3 > 325.0; Cheese, T1 < 7.5, T2 7.5-20.0, T3 > 20.0; Vegetables, T1 < 152.9, T2 152.9-237.2, T3 > 237.2;Tertiles of food groups for men: 
Fruits, T1 < 207.5, T2 207.5-392.9, T3 > 392.9; Whole grains, T1 < 1.0, T2 1.0-17.5, T3 > 17.5; Tertiles of food groups for women: Fruits T1 < 242.9, T2 242.9-
425.0,: Whole grains, T1 < 2.0, T2 2.0-30.0, T3 > 30.0. 
2Model I, analyses were performed using crude conditional logistic regression, without taking into account confounding factors. 
3Model II, analyses were performed using conditional logistic regression analysis adjusted for age (50-59 years old, 60-69 years old), sex, body mass index 
(underweight/normal weight, overweight/obesity), energy intake (kcal/d), physical exercise level (< 15 min/d of cycling/sports, ≥ 15 min/d), smoking 
status and intensity of smoking (never; past: quit smoking ≥ 11 years ago, quit < 11 years ago; Smoker: ≤ 15 cigarettes/d, > 15 cigarettes/d), Deprivation 
Index (quintile 1-3, quintile 4-5) and Predictive Risk Modelling (level 1-2, level 3-4), including food groups separately; Participants with missing data for 
the confounding variables were included as a separate category for these variables. 
4Model III, model II including all the mean food groups. CI: Confidence interval; OR: Odd ratio; T: Tertile.
interfering absorption of those, and lowering intestinal acidity[51]. In addition, 
fermentation of fiber produced butyrate. This short-chain fatty acid showed anti-
inflammatory, anti-proliferation and antineoplastic properties in colonocyte cells 
metabolism through microbiota homeostasis and genetic/epigenetic regulation[52].
Furthermore, our findings suggest that high consumption of whole grains (higher 
than 17.5 g/d in men and 30.0 g/d in women) may decrease the risk of CRC, after 
controlling confounding factors. There is convincing evidence that whole grains help 
to reduce CRC risk[5,53]. The observed reduction in CRC risk associated with high 
consumption of whole grains may partly be attributed to dietary fiber, resistant starch, 
and oligosaccharides that can influence the gut environment. Insoluble fiber increases 
the bulk of luminal contents, diluting potential carcinogens and promoters in the colon 
and decreasing transit time, and, consequently, reduces the exposure of the colonic 
epithelium to harmful compounds[54,55]. Additionally, other components such as 
vitamins (especially B-vitamins), minerals (e.g., magnesium and zinc), phenolic 
compounds, antinutrients (e.g., tannins), and phytoestrogens may also contribute to 
this protection[54].
On the other hand, the consumption of fatty fish (higher than 42.8 g/d) was 
associated with a decreased risk in CRC by about 50% (OR approximately 0.5) 
compared to lower consumption, after adjusting models for covariates. It should be 
noted that the Basque Country population has a higher consumption of total fish and 
fatty fish compared to other Spanish autonomous communities[55,56]. Recent cohort 
studies have observed that fatty fish was inversely associated with CRC incidence[57,58] 
and they have related this association with exposure to long-chain n-3 
polyunsaturated fatty acids[57]. Evidence from animal and in vitro studies indicates that 
n-3 fatty acids present in fatty fish may inhibit carcinogenesis[59]. High intake of n-3 
fatty acids suppresses the production of arachidonic acid-derived eicosanoids such as 
prostaglandin E2 and leukotriene B431. N-3 fatty acids could also suppress the 
expression of inducible nitric oxide synthase and nuclear transcription factor κ B (NF-κ 
B)[60].
In relation to the diet quality, our findings on the MDS and CRC risk are supported 
by those of other researchers[13,61-63], who found significant associations between lower 
risk of CRC and adherence to Mediterranean dietary pattern. However the HEISD was 
not associated with CRC risk, discrepancies in results obtained with the two dietary 
quality indices analysed are probably due to differences in their constructs and scoring 
criteria. The overall MDS was inversely associated with CRC risk, being higher the 
total score in cases with the proximal location of cancer than for those with the distal 
location. These last results contrast with previous findings, which showed that the 
protective effects of adherence to the MD were mainly for distal colon and rectal 
cancer and not for proximal colon cancer[64]. In the total sample, investigation of the 
separate score components showed that whole grain score was lower for cases than for 
controls. This result is consistent with that obtained for the association between whole 
grains consumption and CRC risk.
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Table 6 Diet quality indices in the sample studied
Cases (n = 308) Controls (n = 308)
mean SD mean SD
P value
HEISD components1
Meats 3.1 1.7 3.1 1.7 0.811
Processed meats 2.8 2.0 3.1 2.2 0.162
Legumes 8.6 2.1 8.5 2.3 0.716
Milk/Dairy 9.8 1.2 9.8 1.1 0.797
Fruits 9.1 1.8 9.1 1.9 0.464
Vegetables 8.9 1.7 8.9 1.6 0.816
Grains 9.9 0.9 9.9 1.9 0.862
Sweets 1.6 3.1 1.6 3.0 0.847
Soft-drink 8.8 2.5 8.7 2.6 0.583
Variety 8.0 1.7 8.0 1.7 0.646
Total HEISD 70.7 7.2 70.8 7.9 0.906
MDS components2
Red meats and processed meats 0.7 1.0 0.8 1.2 0.134
Poultry 2.9 1.2 2.9 1.2 0.335
Fish 3.8 1.1 3.8 1.2 0.771
Legumes 2.4 1.2 2.3 1.1 0.482
Full fat dairy 2.0 1.8 2.0 1.9 0.618
Vegetables 4.9 0.6 4.9 0.5 0.599
Fruits 4.6 1.0 4.6 1.0 0.726
Potatoes 2.2 1.5 2.4 1.5 0.054
Whole grains 2.0 2.2 2.3 2.3 0.044
Alcoholic beverages 4.9 0.4 4.9 0.4 0.729
Olive oil 4.9 0.6 4.8 0.8 0.446
Total MDS 35.3 4.5 36.0 4.3 0.027
1Each component can contribute 10 points to the total score and the theoretical range is 0–100. 
2Each component can contribute five points to the total score and the theoretical range is 0–55. HEISD: Healthy Eating Index for Spanish Diet; MDS: Med 
Diet Score; SD: Standard deviation.
Our study has several limitations. First, recall bias inherent in a case-control study 
design cannot be ruled out. The primary concern of this study is the low participation 
rate, which may have limited the representativeness of study samples. The decision to 
participate or not may be influenced by several factors, including social, educational 
and health conditions, which may again correlate with outcome risk factors. Second, 
self-reported data could be subject to measurement errors and the problem of food 
omissions due to memory failure and underreporting of unhealthy habits among 
disease subjects. However, previous validation studies indicate that the self-reported 
dietary information is reported with sufficient accuracy for use in epidemiology 
analyses[65]; and it should be noted that dietary changes are usually modest after 
participating in the CRCSP due to a lack of information and personalized advice[66,67]. 
Another limitation of this type of study could be the selection of controls (selection 
bias). To avoid this type of bias, we obtained controls from the same CRCSP and in the 
same period as cases, thus, it was confirmed that they did not suffer from CRC by 
colonoscopy.
Despite these limitations, the results allow us to conclude that high consumption of 
high-fat cheeses is associated with CRC risk, whereas, a high intake of fiber-containing 
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foods, especially whole grains, and fatty fish, and adherence to the Mediterranean 
dietary pattern was associated with a lower risk for CRC. Future studies are needed to 
better understand the influence of the dietary habits on CRC prevention in this 
population that can provide leads for the design and tailoring of future interventions, 
and guide counselling strategies for promoting a healthy lifestyle.
ARTICLE HIGHLIGHTS
Research background
Epidemiological evidence suggests that some foods may both protect against and 
promote the development of colorectal cancer (CRC). However, foods are not 
consumed in isolation but as part of a dietary pattern; therefore, the actual effect of 
diet on disease risk may be observed only when all components are considered jointly. 
For this purpose, several diet quality indexes have been developed using point 
systems to measure whole diet quality based on the alignment of food choices with 
dietary recommendations.
Research motivation
Some diet quality indexes have been used to begin assessing the relationships between 
overall diet quality and CRC risk, and the results show that high scores in these 
indices are associated with a lower CRC risk. However, the results vary considerably 
according to the index used and other factors such as sex and age. Therefore, there is a 
need to further examine these relationships in diverse population studies.
Research objectives
To study the relationships between food groups, diet quality and CRC risk, in an adult 
population of the Basque Country (North of Spain).
Research methods
This observational study included 308 patients diagnosed with CRC and 308 age- and 
sex-matched subjects as controls. During recruitment, dietary, anthropometric, 
lifestyle, socioeconomic, demographic and health status information was collected. 
Dietary intake was assessed using a short food frequency questionnaire that was 
adapted and validated for this population. Adherence to the dietary recommendations 
was evaluated utilizing the Healthy Eating Index for the Spanish Diet and the 
MedDietScore. Statistical analyses were performed using IBM SPSS Statistics for 
Windows, version 22.0 (IBM Corp., Armonk, NY, United States) and STATA 13.0 
(StataCorp LP, TX, United States). Conditional logistic regressions were used to 
evaluate the associations of food group intakes, diet quality scores, categorized in 
tertiles, with CRC risk.
Research results
The adjusted models for potential confounding factors showed a direct association 
between milk/dairy products consumption, in particular high-fat cheeses [odds ratio 
(OR) third tertile vs first tertile = 1.87, 95% confidence intervals (CI): 1.11-3.16], and 
CRC risk. While the consumption of fiber-containing foods, especially whole grains 
(OR third tertile vs first tertile = 0.62, 95%CI: 0.39-0.98), and fatty fish (OR = 0.53, 
95%CI: 0.27-0.99) was associated with a lower risk for CRC. Moreover, higher MD 
adherence was associated with a reduced CRC risk in adjusted models (OR = 0.40, 
95%CI: 0.20-0.80).
Research conclusions
Direct associations were found for high-fat cheese, whereas an inverse relation was 
reported for fiber-containing foods and fatty fish, as well as adherence to a 
Mediterranean dietary pattern.
Research perspectives
Future studies are needed to better understand the influence of the dietary habits on 
CRC prevention in this population that can provide leads for the design and tailoring 
of future interventions, and guide counselling strategies for promoting a healthy 
lifestyle.
Alegria-Lertxundi I et al. Diet and colorectal cancer risk
WJG https://www.wjgnet.com 4122 July 28, 2020 Volume 26 Issue 28
REFERENCES
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: 
GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J 
Clin 2018; 68: 394-424 [PMID: 30207593 DOI: 10.3322/caac.21492]
1     
Altobelli E, Lattanzi A, Paduano R, Varassi G, di Orio F. Colorectal cancer prevention in Europe: burden of 
disease and status of screening programs. Prev Med 2014; 62: 132-141 [PMID: 24530610 DOI: 
10.1016/j.ypmed.2014.02.010]
2     
Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary 
and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological 
evidence. Int J Cancer 2009; 125: 171-180 [PMID: 19350627 DOI: 10.1002/ijc.24343]
3     
Vucenik I, Stains JP. Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad 
Sci 2012; 1271: 37-43 [PMID: 23050962 DOI: 10.1111/j.1749-6632.2012.06750.x]
4     
World Cancer Research Fund/American Institute for Cancer Research.   Continuous Update Project 
Expert Report 2018. Diet, nutrition, physical activity and colorectal cancer. 2017. Available from: 
https://www.wcrf.org/sites/default/files/Colorectal-cancer-report.pdf
5     
Jacques PF, Tucker KL. Are dietary patterns useful for understanding the role of diet in chronic disease? Am 
J Clin Nutr 2001; 73: 1-2 [PMID: 11124739]
6     
Reedy J, Wirfält E, Flood A, Mitrou PN, Krebs-Smith SM, Kipnis V, Midthune D, Leitzmann M, 
Hollenbeck A, Schatzkin A, Subar AF. Comparing 3 dietary pattern methods--cluster analysis, factor 
analysis, and index analysis--With colorectal cancer risk: The NIH-AARP Diet and Health Study. Am J 
Epidemiol 2010; 171: 479-487 [PMID: 20026579 DOI: 10.1093/aje/kwp393]
7     
Steck SE, Guinter M, Zheng J, Thomson CA. Index-based dietary patterns and colorectal cancer risk: a 
systematic review. Adv Nutr 2015; 6: 763-773 [PMID: 26567200 DOI: 10.3945/an.115.009746]
8     
Reedy J, Mitrou PN, Krebs-Smith SM, Wirfält E, Flood A, Kipnis V, Leitzmann M, Mouw T, Hollenbeck 
A, Schatzkin A, Subar AF. Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet 
and Health Study. Am J Epidemiol 2008; 168: 38-48 [PMID: 18525082 DOI: 10.1093/aje/kwn097]
9     
Miller PE, Cross AJ, Subar AF, Krebs-Smith SM, Park Y, Powell-Wiley T, Hollenbeck A, Reedy J. 
Comparison of 4 established DASH diet indexes: examining associations of index scores and colorectal 
cancer. Am J Clin Nutr 2013; 98: 794-803 [PMID: 23864539 DOI: 10.3945/ajcn.113.063602]
10     
Idigoras I, Arrospide A, Portillo I, Arana-Arri E, Martínez-Indart L, Mar J, de Koning HJ, Lastra R, Soto-
Gordoa M, van der Meulen M, Lansdorp-Vogelaar I. Evaluation of the colorectal cancer screening 
Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model. BMC 
Public Health 2017; 18: 78 [PMID: 28764731 DOI: 10.1186/s12889-017-4639-3]
11     
Banqué M, Raidó B, Masuet C, Ramon JM. Food groups and nutrient intake and risk of colorectal cancer: a 
hospital-based case-control study in Spain. Nutr Cancer 2012; 64: 386-392 [PMID: 22369135 DOI: 
10.1080/01635581.2012.657334]
12     
Castelló A, Amiano P, Fernández de Larrea N, Martín V, Alonso MH, Castaño-Vinyals G, Pérez-Gómez B, 
Olmedo-Requena R, Guevara M, Fernandez-Tardon G, Dierssen-Sotos T, Llorens-Ivorra C, Huerta JM, 
Capelo R, Fernández-Villa T, Díez-Villanueva A, Urtiaga C, Castilla J, Jiménez-Moleón JJ, Moreno V, 
Dávila-Batista V, Kogevinas M, Aragonés N, Pollán M; MCC-Spain researchers. Low adherence to the 
western and high adherence to the mediterranean dietary patterns could prevent colorectal cancer. Eur J Nutr 
2019; 58: 1495-1505 [PMID: 29582162 DOI: 10.1007/s00394-018-1674-5]
13     
Rosato V, Guercio V, Bosetti C, Negri E, Serraino D, Giacosa A, Montella M, La Vecchia C, Tavani A. 
Mediterranean diet and colorectal cancer risk: a pooled analysis of three Italian case-control studies. Br J 
Cancer 2016; 115: 862-865 [PMID: 27537381 DOI: 10.1038/bjc.2016.245]
14     
Alegria-Lertxundi I, Aguirre C, Bujanda L, Fernández FJ, Polo F, Ordovás JM, Etxezarraga MC, Zabalza I, 
Larzabal M, Portillo I, de Pancorbo MM, Palencia-Madrid L, Rocandio AM, Arroyo-Izaga M. Single 
nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control 
study in a Basque population. PLoS One 2019; 14: e0225779 [PMID: 31821333 DOI: 
10.1371/journal.pone.0225779]
15     
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer 
staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474 [PMID: 20180029 DOI: 
10.1245/s10434-010-0985-4]
16     
Rodríguez IT, Ballart JF, Pastor GC, Jordà EB, Val VA. [Validation of a short questionnaire on frequency 
of dietary intake: reproducibility and validity]. Nutr Hosp 2008; 23: 242-252 [PMID: 18560701]
17     
Telleria-Aramburu N, Alegria-Lertxundi, Arroyo-Izaga M. Adaptation, validation and reproducibility of a 
short food frequency questionnaire to assess food group intake in the population resident in the Basque 
Country (Spain). Public Health Nutr 2020; In press
18     
Alegria-Lertxundi I, Alvarez M, Rocandio AM, de Pancorbo MM, Arroyo-Izaga M. Nutritional Adequacy 
and Diet Quality in Colorectal Cancer Patients Postsurgery: A Pilot Study. Nutr Cancer 2016; 68: 577-588 
[PMID: 27144653 DOI: 10.1080/01635581.2016.1158299]
19     
Carbajal A, Sánchez-Muniz FJ. Guía de prácticas.  In: García-Arias, MC García-Fernández Nutrición y 
dietética. León: Secretariado de Publicaciones y Medios Audiovisuales, Universidad de León, 2003: 1-30
20     
Elika. Estudio cuantitativo del consumo de alimentos en la CAPV.  Vitoria-Gasteiz: Dpto. Agricultura, Pesca 
y Alimentación, Gobierno Vasco, 2008
21     
Dapchich V, Salador Castell G, Ribas Barba L, Pérez Rodrigo C, Aranceta Bartrina J, Serra Majem L. 1st ed. 
Madrid: Sociedad Española de Nutrición Comunitaria, 2004: 1-106
22     
Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology 2015; 
148: 1244-60.e16 [PMID: 25575572 DOI: 10.1053/j.gastro.2014.12.035]
23     
Schwingshackl L, Hoffmann G. Does a Mediterranean-Type Diet Reduce Cancer Risk? Curr Nutr Rep 
2016; 5: 9-17 [PMID: 27014505]
24     
Ortega RM, López-Sobaler AM, Andrés P, Requejo AM, Aparicio A, Molinero LM. DIAL software for 
assessing diets and food calculations (for Windows, version 8). Department of Nutrition (UCM) Alce 
25     
Alegria-Lertxundi I et al. Diet and colorectal cancer risk
WJG https://www.wjgnet.com 4123 July 28, 2020 Volume 26 Issue 28
Ingeniería, S.L. Madrid, Spain, 2016. Last access: [accesed: 20/10/2016].  Available from: 
http://www.alceingenieria.net/nutricion/descarga.htm
Norte Navarro AI, Ortiz Moncada R. [Spanish diet quality according to the healthy eating index]. Nutr 
Hosp 2011; 26: 330-336 [PMID: 21666971 DOI: 10.1590/S0212-16112011000200014]
26     
Panagiotakos DB, Milias GA, Pitsavos C, Stefanadis C. MedDietScore: a computer program that evaluates 
the adherence to the Mediterranean dietary pattern and its relation to cardiovascular disease risk. Comput 
Methods Programs Biomed 2006; 83: 73-77 [PMID: 16806570]
27     
Ministerio de Sanidad, Servicios Sociales e Igualdad. Encuesta Nacional de Salud 2011/12.  Madrid: 2013. 
Available from: http://www.ine.es/jaxi/menu.do?typeDpcaxispathD/t15/p419fileDinebase
28     
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ 
Tech Rep Ser 2000; 894: i-xii, 1-253 [PMID: 11234459]
29     
Silva Rodrigues RA, Martinez Espinosa M, Duarte Melo C, Rodrigues Perracini M, Rezende Fett WC, Fett 
CA. New values anthropometry for classification of nutritional status in the elderly. J Nutr Health Aging 
2014; 18: 655-661 [PMID: 25226103 DOI: 10.1007/s12603-014-0451-2]
30     
Domínguez-Berjón MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasarín MI, Ramis R, Saurina C, 
Escolar-Pujolar A. [Constructing a deprivation index based on census data in large Spanish cities(the 
MEDEA project)]. Gac Sanit 2008; 22: 179-187 [PMID: 18579042]
31     
Johns Hopkins University, School of Public Health. The Johns Hopkins University ACG Case-Mix 
System.  Available from: 
http://www.acg.jhsph.org/index.php?option=com_contentview=articleid=46Itemid=61
32     
Verisk Health´s DxCGDCG_Methodology.   Available from: http://www.dxcg.com/resources/library33     
3MTM Clinical Risk Grouping Software.  Available from: 
http://solutions.3m.com/wps/portal/3M/en_US/3M_Health_Information_Systems/HIS/Products/CRG/
34     
Orueta JF, Nuño-Solinis R, Mateos M, Vergara I, Grandes G, Esnaola S. Predictive risk modelling in the 
Spanish population: a cross-sectional study. BMC Health Serv Res 2013; 13: 269 [PMID: 23837560 DOI: 
10.1186/1472-6963-13-269]
35     
Torres Stone RA, Waring ME, Cutrona SL, Kiefe CI, Allison J, Doubeni CA. The association of dietary 
quality with colorectal cancer among normal weight, overweight and obese men and women: a prospective 
longitudinal study in the USA. BMJ Open 2017; 7: e015619 [PMID: 28679675 DOI: 
10.1136/bmjopen-2016-015619]
36     
Doubeni CA, Laiyemo AO, Major JM, Schootman M, Lian M, Park Y, Graubard BI, Hollenbeck AR, Sinha 
R. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in 
the National Institutes of Health-AARP Diet and Health Study. Cancer 2012; 118: 3636-3644 [PMID: 
22898918 DOI: 10.1002/cncr.26677]
37     
Deshpande AD, McQueen A, Coups EJ. Different effects of multiple health status indicators on breast and 
colorectal cancer screening in a nationally representative US sample. Cancer Epidemiol 2012; 36: 270-275 
[PMID: 22079763 DOI: 10.1016/j.canep.2011.10.001]
38     
Romaguera D, Vergnaud AC, Peeters PH, van Gils CH, Chan DS, Ferrari P, Romieu I, Jenab M, Slimani N, 
Clavel-Chapelon F, Fagherazzi G, Perquier F, Kaaks R, Teucher B, Boeing H, von Rüsten A, Tjønneland A, 
Olsen A, Dahm CC, Overvad K, Quirós JR, Gonzalez CA, Sánchez MJ, Navarro C, Barricarte A, Dorronsoro 
M, Khaw KT, Wareham NJ, Crowe FL, Key TJ, Trichopoulou A, Lagiou P, Bamia C, Masala G, Vineis P, 
Tumino R, Sieri S, Panico S, May AM, Bueno-de-Mesquita HB, Büchner FL, Wirfält E, Manjer J, Johansson 
I, Hallmans G, Skeie G, Benjaminsen Borch K, Parr CL, Riboli E, Norat T. Is concordance with World 
Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to 
subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr 2012; 96: 150-163 [PMID: 
22592101 DOI: 10.3945/ajcn.111.031674]
39     
Abbastabar H, Roustazadeh A, Alizadeh A, Hamidifard P, Valipour M, Valipour AA. Relationships of 
colorectal cancer with dietary factors and public health indicators: an ecological study. Asian Pac J Cancer 
Prev 2015; 16: 3991-3995 [PMID: 25987074]
40     
Norat T, Riboli E. Dairy products and colorectal cancer. A review of possible mechanisms and 
epidemiological evidence. Eur J Clin Nutr 2003; 57: 1-17 [PMID: 12548291]
41     
Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E, Norat T. Dairy products and colorectal 
cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 2012; 23: 37-45 [PMID: 
21617020 DOI: 10.1093/annonc/mdr269]
42     
Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, Olsen A, Tjønneland A, Dahm CC, 
Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Nailler L, Kaaks R, Teucher B, Boeing H, Bergmann 
MM, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Tumino R, Vineis P, Panico S, Peeters PH, 
Dik VK, Weiderpass E, Lund E, Garcia JR, Zamora-Ros R, Pérez MJ, Dorronsoro M, Navarro C, Ardanaz E, 
Manjer J, Almquist M, Johansson I, Palmqvist R, Khaw KT, Wareham N, Key TJ, Crowe FL, Fedirko V, 
Gunter MJ, Riboli E. Consumption of dairy products and colorectal cancer in the European Prospective 
Investigation into Cancer and Nutrition (EPIC). PLoS One 2013; 8: e72715 [PMID: 24023767 DOI: 
10.1371/journal.pone.0072715]
43     
Larsson SC, Bergkvist L, Wolk A. High-fat dairy food and conjugated linoleic acid intakes in relation to 
colorectal cancer incidence in the Swedish Mammography Cohort. Am J Clin Nutr 2005; 82: 894-900 
[PMID: 16210722]
44     
Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent 
colorectal cancer. World J Gastroenterol 2009; 15: 5141-5148 [PMID: 19891012]
45     
Ou J, DeLany JP, Zhang M, Sharma S, O'Keefe SJ. Association between low colonic short-chain fatty acids 
and high bile acids in high colon cancer risk populations. Nutr Cancer 2012; 64: 34-40 [PMID: 22136517 
DOI: 10.1080/01635581.2012.630164.]
46     
Ajouz H, Mukherji D, Shamseddine A. Secondary bile acids: an underrecognized cause of colon cancer. 
World J Surg Oncol 2014; 12: 164 [PMID: 24884764 DOI: 10.1186/1477-7819-12-164]
47     
Dahm CC, Keogh RH, Spencer EA, Greenwood DC, Key TJ, Fentiman IS, Shipley MJ, Brunner EJ, Cade 
JE, Burley VJ, Mishra G, Stephen AM, Kuh D, White IR, Luben R, Lentjes MA, Khaw KT, Rodwell 
48     
Alegria-Lertxundi I et al. Diet and colorectal cancer risk
WJG https://www.wjgnet.com 4124 July 28, 2020 Volume 26 Issue 28
Bingham SA. Dietary fiber and colorectal cancer risk: a nested case-control study using food diaries. J Natl 
Cancer Inst 2010; 102: 614-626 [PMID: 20407088 DOI: 10.1093/jnci/djq092]
Tan J, Chen YX. Dietary and Lifestyle Factors Associated with Colorectal Cancer Risk and Interactions with 
Microbiota: Fiber, Red or Processed Meat and Alcoholic Drinks. Gastrointest Tumors 2016; 3: 17-24 
[PMID: 27722153]
49     
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta 
ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, 
Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, 
Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MacIntyre MF, Marczak L, Marquez 
N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, 
Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, 
Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, 
Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, 
Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernabé E, Betsu B, Binagwaho A, 
Boneya D, Campos-Nonato I, Castañeda-Orjuela C, Catalá-López F, Chiang P, Chibueze C, Chitheer A, 
Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme 
D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, G/Hiwot TT, Gebru A, Gopalani S, Hailu A, 
Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, 
Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, El Razek 
HMA, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste 
DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, 
Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, 
Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, Søreide K, Satpathy M, Sawhney M, Sepanlou SG, 
Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan 
MB, Sykes BL, Tabarés-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, 
Uzochukwu BSC, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, 
Younis MZ, Yu C, Zaidi Z, Zaki MES, Zenebe ZM, Murray CJL, Naghavi M. Global, Regional, and 
National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-
Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of 
Disease Study. JAMA Oncol 2017; 3: 524-548 [PMID: 27918777 DOI: 10.1001/jamaoncol.2016.5688]
50     
Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T. Dietary fibre, whole grains, and 
risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 
2011; 343: d6617 [PMID: 22074852 DOI: 10.1136/bmj.d6617].]
51     
Yang J, Yu J. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we 
get. Protein Cell 2018; 9: 474-487 [PMID: 29713943 DOI: 10.1007/s13238-018-0543-6]
52     
Vieira AR, Abar L, Chan DSM, Vingeliene S, Polemiti E, Stevens C, Greenwood D, Norat T. Foods and 
beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of 
the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol 2017; 28: 1788-1802 [PMID: 
28407090 DOI: 10.1093/annonc/mdx171.]
53     
Slavin JL, Martini MC, Jacobs DR Jr, Marquart L. Plausible mechanisms for the protectiveness of whole 
grains. Am J Clin Nutr 1999; 70: 459S-463S [PMID: 10479218 DOI: 10.1093/ajcn/70.3.459s.]
54     
Ministerio de Agricultura, Alimentación y Medio Ambiente, Gobierno de España.   Informe del Consumo 
de Alimentación en España 2014. Available from: https://www.mapa.gob.es/es/alimentacion/temas/consumo-
y-comercializacion-y-distribucion-alimentaria/informeconsumoalimentacion2014_tcm30- 
104149.pdf
55     
Federación Española del Corazón (FEC).   Encuesta de consumo de pescado azul en España 2015. 
Available from: https://fundaciondelcorazon.com/prensa/notas-de-prensa/2773-la-poblacion-adulta-espanola-
suspende-en-el-consumo-de-pescado-azul-recomendado-.html
56     
Aglago EK, Huybrechts I, Murphy N, Casagrande C, Nicolas G, Pischon T, Fedirko V, Severi G, Boutron-
Ruault MC, Fournier A, Katzke V, Kühn T, Olsen A, Tjønneland A, Dahm CC, Overvad K, Lasheras C, 
Agudo A, Sánchez MJ, Amiano P, Huerta JM, Ardanaz E, Perez-Cornago A, Trichopoulou A, Karakatsani 
A, Martimianaki G, Palli D, Pala V, Tumino R, Naccarati A, Panico S, Bueno-de-Mesquita B, May A, 
Derksen JWG, Hellstrand S, Ohlsson B, Wennberg M, Van Guelpen B, Skeie G, Brustad M, Weiderpass E, 
Cross AJ, Ward H, Riboli E, Norat T, Chajes V, Gunter MJ. Consumption of Fish and Long-chain n-3 
Polyunsaturated Fatty Acids Is Associated With Reduced Risk of Colorectal Cancer in a Large European 
Cohort. Clin Gastroenterol Hepatol 2020; 18: 654-666.e6 [PMID: 31252190 DOI: 
10.1016/j.cgh.2019.06.031]
57     
Spencer EA, Key TJ, Appleby PN, Dahm CC, Keogh RH, Fentiman IS, Akbaraly T, Brunner EJ, Burley V, 
Cade JE, Greenwood DC, Stephen AM, Mishra G, Kuh D, Luben R, Mulligan AA, Khaw KT, Rodwell SA. 
Meat, poultry and fish and risk of colorectal cancer: pooled analysis of data from the UK dietary cohort 
consortium. Cancer Causes Control 2010; 21: 1417-1425 [PMID: 20437091]
58     
Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and 
amounts of dietary fatty acids. Cancer Res 2001; 61: 1927-1933 [PMID: 11280748]
59     
Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the 
prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004; 79: 935-945 [PMID: 
15159222]
60     
Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. Mediterranean Diet: Prevention of Colorectal 
Cancer. Front Nutr 2017; 4: 59 [PMID: 29259973 DOI: 10.3389/fnut.2017.00059]
61     
Jafari Nasab S, Bahrami A, Rafiee P, Hekmatdoust A, Ghanavati M, Rashidkhani B, Sadeghi A, Asadzadeh 
Aghdaei H, Naja F, Hejazi E. Healthy Eating Index-2010 and Mediterranean-Style Dietary Pattern Score and 
the risk of colorectal cancer and adenoma: a case-control study. Nutr Cancer 2019; 1-10 [PMID: 31687849 
DOI: 10.1080/01635581.2019.1683212]
62     
Grosso G, Biondi A, Galvano F, Mistretta A, Marventano S, Buscemi S, Drago F, Basile F. Factors 
associated with colorectal cancer in the context of the Mediterranean diet: a case-control study. Nutr Cancer 
63     
Alegria-Lertxundi I et al. Diet and colorectal cancer risk
WJG https://www.wjgnet.com 4125 July 28, 2020 Volume 26 Issue 28
2014; 66: 558-565 [PMID: 24754383 DOI: 10.1080/01635581.2014.902975]
Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ, Dahm CC, Overvad K, Olsen A, 
Tjønneland A, Cottet V, Boutron-Ruault MC, Morois S, Grote V, Teucher B, Boeing H, Buijsse B, 
Trichopoulos D, Adarakis G, Tumino R, Naccarati A, Panico S, Palli D, Bueno-de-Mesquita HB, van 
Duijnhoven FJ, Peeters PH, Engeset D, Skeie G, Lund E, Sánchez MJ, Barricarte A, Huerta JM, Quirós JR, 
Dorronsoro M, Ljuslinder I, Palmqvist R, Drake I, Key TJ, Khaw KT, Wareham N, Romieu I, Fedirko V, 
Jenab M, Romaguera D, Norat T, Trichopoulou A. Mediterranean diet and colorectal cancer risk: results 
from a European cohort. Eur J Epidemiol 2013; 28: 317-328 [PMID: 23579425 DOI: 
10.1007/s10654-013-9795-x]
64     
Kumanyika SK, Mauger D, Mitchell DC, Phillips B, Smiciklas-Wright H, Palmer JR. Relative validity of 
food frequency questionnaire nutrient estimates in the Black Women's Health Study. Ann Epidemiol 2003; 
13: 111-118 [PMID: 12559670]
65     
Berstad P, Løberg M, Larsen IK, Kalager M, Holme Ø, Botteri E, Bretthauer M, Hoff G. Long-term lifestyle 
changes after colorectal cancer screening: randomised controlled trial. Gut 2015; 64: 1268-1276 [PMID: 
25183203 DOI: 10.1136/gutjnl-2014-307376]
66     
Hand R, Antrim LR, Crabtree DA. Differences in the technical and applied nutrition knowledge of older 
adults. J Nutr Elder 1990; 9: 23-34 [PMID: 2277329 DOI: 10.1007/s00520-012-1487-7]
67     
Published by Baishideng Publishing Group Inc 
7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA 
Telephone: +1-925-3991568 
E-mail: bpgoffice@wjgnet.com 
Help Desk: https://www.f6publishing.com/helpdesk 
https://www.wjgnet.com
© 2020 Baishideng Publishing Group Inc. All rights reserved.
